International Journal of Cancer Management

Published by: Kowsar

The Effect of Polymorphisms on the Ala 119 Ser Gene Cytochrome P450 1B1*2 on the Susceptibility of Iranian Women to Develop Breast Cancer

Fereshteh Moheb Afzali 1 , Zahra Tahmasebi Fard 2 , 3 , * and Mohammad Esmaeil Akbari 2
Authors Information
1 Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences and Technology, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, IR Iran (IAUPS)
2 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Department of Biology, Roudehen Branch, Islamic Azad University, Roudehen, IR Iran
Article information
  • International Journal of Cancer Management: March 2017, 10 (3); e4042
  • Published Online: February 25, 2017
  • Article Type: Research Article
  • Received: October 3, 2015
  • Revised: May 28, 2016
  • Accepted: February 14, 2017
  • DOI: 10.5812/ijcp.4042

To Cite: Moheb Afzali F, Tahmasebi Fard Z, Akbari M E. The Effect of Polymorphisms on the Ala 119 Ser Gene Cytochrome P450 1B1*2 on the Susceptibility of Iranian Women to Develop Breast Cancer, Int J Cancer Manag. 2017 ; 10(3):e4042. doi: 10.5812/ijcp.4042.

Abstract
Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Kumar V, Abbas AK, Fausto N. Cellular adaptations, cell injury, and cell death. Robbins and Cotran Pathologic Basis of Disease. 2005; : 3-46
  • 2. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007; 13(4): 383-91[DOI][PubMed]
  • 3. Martin M. Molecular biology of breast cancer. Clin Transl Oncol. 2006; 8(1): 7-14[PubMed]
  • 4. Brunicardi F, Brandt M, Andersen D, Billiar T, Dunn D, Hunter JG, et al. Schwartz's Principles of surgery ABSITE and Board Review. 2010;
  • 5. Baldwin WS, Marko PB, Nelson DR. The cytochrome P450 (CYP) gene superfamily in Daphnia pulex. BMC Genomics. 2009; 10: 169[DOI][PubMed]
  • 6. Pastina I, Giovannetti E, Chioni A, Sissung TM, Crea F, Orlandini C, et al. Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients. BMC Cancer. 2010; 10: 511[DOI][PubMed]
  • 7. Trubicka J, Grabowska-Klujszo E, Suchy J, Masojc B, Serrano-Fernandez P, Kurzawski G, et al. Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility. BMC Cancer. 2010; 10: 420[DOI][PubMed]
  • 8. Xu W, Zhou Y, Hang X, Shen D. Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis. Mol Biol Rep. 2012; 39(3): 2821-9[DOI][PubMed]
  • 9. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 1996; 56(13): 2979-84[PubMed]
  • 10. Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, Gillam EM, et al. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis. 1999; 20(8): 1607-13[PubMed]
  • 11. McFadyen MC, Cruickshank ME, Miller ID, McLeod HL, Melvin WT, Haites NE, et al. Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. Br J Cancer. 2001; 85(2): 242-6[DOI][PubMed]
  • 12. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD, et al. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res. 1997; 57(14): 3026-31[PubMed]
  • 13. Murray GI, Melvin WT, Greenlee WF, Burke MD. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol. 2001; 41: 297-316[DOI][PubMed]
  • 14. Spivack SD, Hurteau GJ, Reilly AA, Aldous KM, Ding X, Kaminsky LS. CYP1B1 expression in human lung. Drug Metab Dispos. 2001; 29(6): 916-22[PubMed]
  • 15. Okobia MN, Bunker CH, Garte SJ, Zmuda JM, Ezeome ER, Anyanwu SN, et al. Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study. Infect Agent Cancer. 2009; 4 Suppl 1[DOI][PubMed]
  • 16. Matyjasik J, Cybulski C, Masojc B, Jakubowska A, Serrano-Fernandez P, Gorski B, et al. CYP1B1 and predisposition to breast cancer in Poland. Breast Cancer Res Treat. 2007; 106(3): 383-8[DOI][PubMed]
  • 17. Purnapatre K, Khattar SK, Saini KS. Cytochrome P450s in the development of target-based anticancer drugs. Cancer Lett. 2008; 259(1): 1-15[DOI][PubMed]
  • 18. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res. 2003; 63(14): 3913-8[PubMed]
  • 19. Bailey LR, Roodi N, Dupont WD, Parl FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res. 1998; 58(22): 5038-41[PubMed]
  • 20. Faas BH, Simsek S, Bleeker PM, Overbeeke MA, Cuijpers HT, von dem Borne AE, et al. Rh E/e genotyping by allele-specific primer amplification. Blood. 1995; 85(3): 829-32[PubMed]
  • 21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 1989;
  • 22. Kumar V, Singh S, Ahmed RS, Banerjee BD, Ahmed T, Pasha ST. Frequency of common CYP1B1 polymorphic variations in Delhi population of Northern India. Environ Toxicol Pharmacol. 2009; 28(3): 392-6[DOI][PubMed]
  • 23. Caporaso N, Goldstein A. Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics. 1995; 5(2): 59-63[PubMed]
  • 24. Cancer. 2014;
  • 25. Horwitz KB, McGuire WL. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem. 1978; 253(7): 2223-8[PubMed]
  • 26. Klijn JG, Berns EM, Foekens JA. Prognostic factors and response to therapy in breast cancer. Cancer Surv. 1993; 18: 165-98[PubMed]
  • 27. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev. 1993; 15(1): 48-65[PubMed]
  • 28. Brown TA. Gene cloning and DNA analysis: an introduction. 2016;
  • 29. Laroche-Clary A, Le Morvan V, Yamori T, Robert J. Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro models. Mol Cancer Ther. 2010; 9(12): 3315-21[DOI][PubMed]
  • 30. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med. 2002; 137(8): 678-87[PubMed]
  • 31. Colditz GA. Epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14(4): 768-72[DOI][PubMed]
  • 32. Russo J, Russo IH. Genotoxicity of steroidal estrogens. Trends Endocrinol Metab. 2004; 15(5): 211-4[DOI][PubMed]
  • 33. Cho YJ, Hur SE, Lee JY, Song IO, Moon HS, Koong MK, et al. Single nucleotide polymorphisms and haplotypes of the genes encoding the CYP1B1 in Korean women: no association with advanced endometriosis. J Assist Reprod Genet. 2007; 24(7): 271-7[DOI][PubMed]
  • 34. Johnson-Thompson MC, Guthrie J. Ongoing research to identify environmental risk factors in breast carcinoma. Cancer. 2000; 88(5 Suppl): 1224-9[PubMed]
  • 35. Zhang H, Li L, Xu Y. CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis. PLoS One. 2013; 8(7)[DOI][PubMed]
  • 36. Feigelson HS, Henderson BE. Estrogens and breast cancer. Carcinogenesis. 1996; 17(11): 2279-84[PubMed]
  • 37. Hunter DJ, Spiegelman D, Adami HO, van den Brandt PA, Folsom AR, Goldbohm RA, et al. Non-dietary factors as risk factors for breast cancer, and as effect modifiers of the association of fat intake and risk of breast cancer. Cancer Causes Control. 1997; 8(1): 49-56[PubMed]
  • 38. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013; 138(1): 103-41[DOI][PubMed]
  • 39. Kocabas NA, Sardas S, Cholerton S, Daly AK, Karakaya AE. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch Toxicol. 2002; 76(11): 643-9[DOI][PubMed]
  • 40. Watanabe J, Shimada T, Gillam EM, Ikuta T, Suemasu K, Higashi Y, et al. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics. 2000; 10(1): 25-33[PubMed]
  • 41. Jiao H, Liu C, Guo W, Peng L, Chen Y, Martin FL. Association of CYP1B1 Polymorphisms with Breast Cancer: A Case-Control Study in the Han Population in Ningxia Hui Autonomous Region, P. R. China. Biomark Insights. 2010; 5: 21-7[PubMed]
  • 42. Economopoulos KP, Sergentanis TN. Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010; 122(2): 545-51[DOI][PubMed]
  • 43. Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson HW, et al. Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009; 18(5): 1461-7[DOI][PubMed]
  • 44. Rylander-Rudqvist T, Wedren S, Granath F, Humphreys K, Ahlberg S, Weiderpass E, et al. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk. Carcinogenesis. 2003; 24(9): 1533-9[DOI][PubMed]
  • 45. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 2000; 60(13): 3440-4[PubMed]
  • 46. Ye Y, Cheng X, Luo HB, Liu L, Li YB, Hou YP. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. J Assist Reprod Genet. 2008; 25(8): 389-94[DOI][PubMed]
  • 47. Bhattacharjee A, Banerjee D, Mookherjee S, Acharya M, Banerjee A, Ray A, et al. Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma. Mol Vis. 2008; 14: 841-50[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments